Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18; 31(1):46-54.
View in:
PubMed
subject areas
Adalimumab
Adult
Aged
Antibodies, Monoclonal
Anti-Inflammatory Agents
Female
Humans
Male
Middle Aged
Prospective Studies
Sarcoidosis, Pulmonary
Time Factors
Treatment Outcome
authors with profiles
Mary Elizabeth Strek
Douglas Kyle Hogarth
Edward Naureckas